110 related articles for article (PubMed ID: 18430905)
1. Antipsychotic-induced weight gain in patients with schizophrenia.
Llewellyn DJ; Naughton F
JAMA; 2008 Apr; 299(16):1898-9; author reply 1899-900. PubMed ID: 18430905
[No Abstract] [Full Text] [Related]
2. Antipsychotic-induced weight gain in patients with schizophrenia.
Venkatasubramanian G
JAMA; 2008 Apr; 299(16):1899; author reply 1899-900. PubMed ID: 18430906
[No Abstract] [Full Text] [Related]
3. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study].
Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C
Recenti Prog Med; 2009 Feb; 100(2):103. PubMed ID: 19350804
[No Abstract] [Full Text] [Related]
5. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.
Wang M; Tong JH; Zhu G; Liang GM; Yan HF; Wang XZ
Schizophr Res; 2012 Jun; 138(1):54-7. PubMed ID: 22398127
[TBL] [Abstract][Full Text] [Related]
6. Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia.
Cortés B; Bécker J; Mories Álvarez MT; Marcos AI; Molina V
Psychiatry Clin Neurosci; 2014 Feb; 68(2):127-32. PubMed ID: 24552633
[TBL] [Abstract][Full Text] [Related]
7. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism.
Reynolds GP; Zhang ZJ; Zhang XB
Lancet; 2002 Jun; 359(9323):2086-7. PubMed ID: 12086765
[TBL] [Abstract][Full Text] [Related]
8. Weight gain and first-generation antipsychotics: experience from a developing country.
Yoon CK
J Clin Psychopharmacol; 2008 Oct; 28(5):574-6. PubMed ID: 18794660
[No Abstract] [Full Text] [Related]
9. [Non-Pharmacological Interventions for the Prevention of Weight Gain in Schizophrenic Patients Treated with Antipsychotic Medication].
Fink A; Cieslak S; Rosenbach F
Psychiatr Prax; 2015 Oct; 42(7):359-69. PubMed ID: 26158719
[TBL] [Abstract][Full Text] [Related]
10. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
[TBL] [Abstract][Full Text] [Related]
11. Non-pharmacological interventions for preventing weight gain in patients with first episode schizophrenia or bipolar disorder: A systematic review.
Nyboe L; Lemcke S; Møller AV; Stubbs B
Psychiatry Res; 2019 Nov; 281():112556. PubMed ID: 31521840
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study on the impact of antipsychotic treatment on serum leptin in schizophrenia.
Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty TK; Gangadhar BN
Clin Neuropharmacol; 2010; 33(6):288-92. PubMed ID: 21060283
[TBL] [Abstract][Full Text] [Related]
13. Almost all antipsychotics result in weight gain: a meta-analysis.
Bak M; Fransen A; Janssen J; van Os J; Drukker M
PLoS One; 2014; 9(4):e94112. PubMed ID: 24763306
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics and weight gain.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):46-58. PubMed ID: 19667655
[TBL] [Abstract][Full Text] [Related]
15. [Weight gain and antipsychotic drug treatment].
Patri E; Dantchev N; Martinez M
Encephale; 2000; 26(6):93-7. PubMed ID: 11217543
[TBL] [Abstract][Full Text] [Related]
16. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
Zhang ZJ; Yao ZJ; Zhang XB; Chen JF; Sun J; Yao H; Hou G; Zhang XB
Acta Pharmacol Sin; 2003 Mar; 24(3):235-40. PubMed ID: 12617772
[TBL] [Abstract][Full Text] [Related]
17. Weight changes and their associations with demographic and clinical characteristics in risperidone maintenance treatment for schizophrenia.
Xiang YT; Wang CY; Ungvari GS; Kreyenbuhl JA; Chiu HF; Lai KY; Lee EH; Bo QJ; Dixon LB
Pharmacopsychiatry; 2011 Jun; 44(4):135-41. PubMed ID: 21710403
[TBL] [Abstract][Full Text] [Related]
18. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
19. The use of psychiatric drugs and worsening body mass index among inpatients with schizophrenia.
Wang PS; Wu SL; Ching HY
Int Clin Psychopharmacol; 2014 Jul; 29(4):235-8. PubMed ID: 24398897
[TBL] [Abstract][Full Text] [Related]
20. Weight change with atypical antipsychotics in the treatment of schizophrenia.
Haddad P
J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
